EUVIMEDEUVIMED entdecken
Crossref

Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains

Rıza Adaleti iD, Yaşar Nakipoğlu, Şeyma Çalık, Neslihan Arıcı, Nilgün Kansak, Seniha Şenbayrak, Sebahat Aksaray

Acta Microbiologica et Immunologica Hungarica · 2023

DOI: 10.1556/030.2023.02015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2023. Verfasst von Rıza Adaleti und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Health Sciences, Haydarpaşa Numune Training and Research Hospital, Laboratory of Medical Microbiology, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Fosfomycin, Carbapenem-Resistant Enterobacteriaceae, Klebsiella Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) is increasing worldwide, and very limited number of effective antibiotics are available for therapy. In our study, the in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against CRKP strains was investigated. The efficiency of meropenem/polymyxin B and meropenem/fosfomycin combinations was tested by checkerboard microdilution and checkerboard agar dilution methods, respectively, against 21 CRKP strains containing major carbapenem resistant genes (7 bla KPC , 7 bla OXA-48 gene, and 7 bla OXA-48+ bla NDM ), and seven additional CRKP strains without carbapenemase genes. Among the 28 CRKP strains, the meropenem/polymyxin B combination was synergistic in ten (35.7%), partially synergistic in 12 (42.8%), and indifferent in six (21.4%) isolates. The meropenem/fosfomycin combination was found to be synergistic in three isolates (10.7%), partially synergistic in 20 (71.4%), and indifferent in five (17.8%). In 21 strains containing carbapenem resistance genes, meropenem/polymyxin B and meropenem/fosfomycin combinations exhibited synergistic/partial synergistic effects in 15 (71.4%) and 16 (76.2%) strains, respectively, compared to 100% synergistic/partial synergistic efficiency in both combinations in seven strains free of carbapenemase genes. No antagonistic effect was detected in either combination. Regardless of presence or absence of carbapenem resistance genes, meropenem/polymyxin B and meropenem/fosfomycin combinations both demonstrated high synergistic and partial synergistic activity against 78.4% and 82.1% of CRKP strains, respectively. Also, they have no antagonistic effects and can be used successfully to prevent therapeutic failure with monotherapy, according to our in vitro studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FosfomycinCarbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsHumansMeropenemPolymyxin BKlebsiella pneumoniaeAnti-Bacterial AgentsCarbapenemsbeta-LactamasesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Klebsiella pneumoniaeantibiotic combinationfosfomycinin vitromeropenempolymyxin B

Substanzen

MeropenemFosfomycinPolymyxin BAnti-Bacterial AgentsCarbapenemsbeta-Lactamases

Autor:innen und Institutionen

  • 1University of Health Sciences, Haydarpaşa Numune Training and Research Hospital, Laboratory of Medical Microbiology, Istanbul, Türkiye.
  • 2Department of Medical Microbiology, Istanbul Faculty of Medicine, Istanbul University, 34093, Capa/Istanbul, Türkiye.
  • 3Ministry of Health, Directorate of Public Health, Amasya, Türkiye.
  • 4Department of Infectious Diseases and Clinical Microbiology, Hamidiye Medical Faculty, University of Health Sciences, Istanbul, Türkiye.
  • 5Department of Medical Microbiology, Hamidiye Medical Faculty, University of Health Sciences, Istanbul, Türkiye.

ORCID-Profile: Rıza Adaleti

Zitieren

APA

Adaleti, R., Nakipoğlu, Y., Çalık, Ş., Arıcı, N., Kansak, N., Şenbayrak, S., & Aksaray, S. (2023). Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2023.02015

Vancouver

Adaleti R, Nakipoğlu Y, Çalık Ş, Arıcı N, Kansak N, Şenbayrak S, et al. Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains. Acta Microbiologica et Immunologica Hungarica. 2023. doi:10.1556/030.2023.02015

BibTeX
@article{Adaleti2023,
  author = {Adaleti, Rıza and Nakipoğlu, Yaşar and Çalık, Şeyma and Arıcı, Neslihan and Kansak, Nilgün and Şenbayrak, Seniha and Aksaray, Sebahat},
  title = {Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2023},
  doi = {10.1556/030.2023.02015}
}
Kostenlos starten →